K2M Group Holdings, Inc. (NASDAQ:KTWO) announced its earnings results on Wednesday. The medical device company reported ($0.20) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.19) by ($0.01), Briefing.com reports. K2M Group Holdings had a negative net margin of 16.21% and a negative return on equity of 15.45%. The business had revenue of $62.65 million for the quarter, compared to analyst estimates of $62.69 million. During the same period in the prior year, the company earned ($0.19) earnings per share. The company’s quarterly revenue was up 5.6% on a year-over-year basis.

Several research analysts recently issued reports on KTWO shares. Oppenheimer Holdings, Inc. reaffirmed a “buy” rating on shares of K2M Group Holdings in a research report on Tuesday, July 11th. Cowen and Company restated a “buy” rating and issued a $26.00 target price on shares of K2M Group Holdings in a research note on Wednesday, July 19th. BidaskClub upgraded K2M Group Holdings from a “hold” rating to a “buy” rating in a research note on Wednesday, July 19th. Royal Bank Of Canada restated a “buy” rating and issued a $26.00 target price on shares of K2M Group Holdings in a research note on Thursday, July 20th. Finally, Needham & Company LLC restated a “buy” rating on shares of K2M Group Holdings in a research note on Wednesday, August 2nd. One research analyst has rated the stock with a sell rating, one has assigned a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the company. The company has an average rating of “Buy” and an average price target of $25.00.

In related news, insider John Philip Md Kostuik sold 1,090 shares of the company’s stock in a transaction that occurred on Tuesday, August 15th. The stock was sold at an average price of $24.08, for a total value of $26,247.20. Following the sale, the insider now owns 201,961 shares of the company’s stock, valued at approximately $4,863,220.88. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, CFO Gregory S. Cole sold 2,350 shares of the company’s stock in a transaction that occurred on Tuesday, August 15th. The shares were sold at an average price of $24.08, for a total value of $56,588.00. Following the completion of the sale, the chief financial officer now directly owns 55,158 shares in the company, valued at approximately $1,328,204.64. The disclosure for this sale can be found here. Insiders have sold a total of 44,129 shares of company stock worth $1,033,644 in the last three months. Corporate insiders own 5.80% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This piece of content was first published by American Banking News and is the property of of American Banking News. If you are viewing this piece of content on another site, it was copied illegally and reposted in violation of US and international copyright laws. The legal version of this piece of content can be read at https://www.americanbankingnews.com/2017/11/01/k2m-group-holdings-inc-ktwo-releases-earnings-results-misses-estimates-by-0-04-eps.html.

K2M Group Holdings Company Profile

K2M Group Holdings, Inc is a medical device company focused on designing, developing and commercializing spine and minimally invasive technologies and techniques. The Company’s solutions are focused on achieving three-dimensional Total Body Balance. Its spine products are used by spine surgeons to treat spinal pathologies, such as deformity (primarily scoliosis), trauma and tumor.

Earnings History for K2M Group Holdings (NASDAQ:KTWO)

Receive News & Ratings for K2M Group Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for K2M Group Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.